Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
Journal of Cardiac Failure|October 30, 2003
A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUSMichael J Domanski, Heidi Krause-Steinrauf, Barry M Massie, et al.
JACC. Cardiovascular Interventions|August 12, 2017
In-Hospital Outcomes of Percutaneous Coronary Intervention in America's Safety Net: Insights From the NCDR Cath-PCI RegistryTushar Acharya, Adam C Salisbury, John A Spertus, et al.
Annals of Global Health|August 26, 2024
Global Community Health Screening and Educational Intervention for Early Detection of Cardiometabolic Renal DiseaseNatalie L Nabaty, Tushar Menon, Garrett Trang, et al.
Lancet (London, England)|September 12, 2006
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets studyPrakash Deedwania, Philip Barter, Rafael Carmena, et al.
The American Journal of Medicine|December 28, 2020
Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by CongestionCharles Faselis, Phillip H Lam, Samir Patel, et al.
International Journal of Cardiology|October 16, 2010
Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched studyMustafa I Ahmed, Marjan Mujib, Ravi V Desai, et al.
European Heart Journal|October 12, 2017
Fibrosis as measured by the biomarker, tissue inhibitor metalloproteinase-1, predicts mortality in Age Gene Environment Susceptibility-Reykjavik (AGES-Reykjavik) StudyGina LaRocca, Thor Aspelund, Anders M Greve, et al.
The American Journal of Medicine|August 5, 2018
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart RatePhillip H Lam, Neha Gupta, Daniel J Dooley, et al.
International Journal of Cardiology|December 16, 2014
Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fractionMichel White, Kanan Patel, Guillem Caldentey, et al.
JAMA Cardiology|August 14, 2020
Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical TrialPrakash Deedwania, Sabina A Murphy, Andre Scheen, et al.
Pageof 18